Epigenetic Reprogramming of Cell Cycle Genes by ACK1 Promotes Breast Cancer Resistance to CDK4/6 Inhibitor

Immunohistochemical studies of tissue microarray revealed increased activation of non-receptor tyrosine kinase, ACK1 in most of the breast cancer subtypes, independent of their hormone receptor status.